LBF20303PG06: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR1725 | |LipidBank=XPR1725 | ||
|LipidMaps=LMFA03010045 | |LipidMaps=LMFA03010045 | ||
|SysName=(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (5-cis | |SysName=(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (cis-5,trans-13,cis-17) -trien-1-oic acid | ||
|Common Name=&&Prostaglandin I_3&&(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid&& | |Common Name=&&Prostaglandin I_3&&(6,9alpha) -Epoxy- (11alpha,15S) -dihydroxy-prosta- (5Z,13E,17Z) -trien-1-oic acid&& | ||
|Source=PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase. | |Source=PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase. |
Latest revision as of 09:00, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1725 |
LipidMaps | LMFA03010045 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20303PG06 |
Prostaglandin I3 | |
---|---|
Structural Information | |
(6,9α) -Epoxy- (11α,15S) -dihydroxy-prosta- (cis-5,trans-13,cis-17) -trien-1-oic acid | |
| |
Formula | C20H30O5 |
Exact Mass | 350.20932407 |
Average Mass | 350.4492 |
SMILES | C(=CC[C@@H](O)C=C[C@H]([C@H]12)[C@H](O)C[C@H](O[C@@H](C2)C=CCCC(O)=O)1)CC |
Physicochemical Information | |
PGI3 is synthesized from EPA by cyclooxygenase and PGI synthase. | |
PGI3 has equal ability to PGI2 in inhibitting human platelet aggregation. Mann_NJ et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|